Skip to main content
. 2020 Dec 9;8:72. doi: 10.1186/s40364-020-00253-w

Fig. 7.

Fig. 7

Ibrutinib-regulated pathways in immune cells. a UMAP representation of T cytotoxic signature in immune cells under ibrutinib treatment. b Cell quantification according to cytotoxic, activation and exhaustion gene scores c Percent of CD69 or PD1 expressing cells quantified by ADT-labeling